Form 4: Director Michael R. Jaff Increases Stake in HeartBeam

Director Michael R. Jaff acquired 31,250 shares of HeartBeam, Inc. common stock as part of a recent public offering.

Summary

• Director Michael R. Jaff purchased 31,250 shares of HeartBeam, Inc. (BEAT) common stock.
• The transaction occurred on April 16, 2026, at a price of $0.80 per share.
• The purchase was made in connection with the company's underwritten public offering of 12,500,000 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive signal because a director is putting personal capital into the company during a public offering, suggesting confidence in the firm's future.

Positives

• Insider confidence is demonstrated by a director participating in the company's public offering.
• The purchase of 31,250 shares indicates alignment between management and shareholder interests.

Negatives

• The purchase price of $0.80 per share reflects the pricing of the recent public offering, which may indicate downward pressure on the stock price.

Risks

• The company is actively utilizing public offerings to raise capital, which may lead to shareholder dilution.

Future Outlook

The filing does not provide specific forward-looking guidance, but notes the completion of a 12,500,000 share public offering.

Industry Context

StockSavvy.ai notes that insider participation in public offerings is generally viewed as a positive signal of management's belief in the company's long-term strategic direction, particularly in the medical technology sector.

Comparison to Industry Standards

• Insider participation in capital raises is a standard practice for small-cap biotech and medtech firms to signal stability to the market.

Related Party Transactions

• The shares are held indirectly by the Reporting Person under the entity Open Book Healthcare.

Stakeholder Impact

• Shareholders may view the director's participation as a vote of confidence, potentially stabilizing sentiment following the dilution from the public offering.

Next Steps

• Continued monitoring of insider ownership filings for further accumulation or divestment.

Key Dates

Keywords

HeartBeam, BEAT, Insider Trading, Form 4, Public Offering, Michael R. Jaff